AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117961	Articles
99395	Press releases

Home
Companies
AMOEBA

BRIEF

published on 10/03/2024 at 17:50, 1 year 2 months ago

Amoéba confirme son pivot stratégique au premier semestre 2024

Stratégie AMOEBA Biocontrôle Cosmétique GreenTech
BRIEF

published on 10/03/2024 at 17:50, 1 year 2 months ago

Amoéba confirms its strategic pivot in the first half of 2024

AMOEBA Strategy Biocontrol GreenTech Cosmetic
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 year 2 months ago

Amoéba : un premier semestre 2024 confirmant le pivot stratégique vers une entreprise industrielle et commerciale dès 2025
Amoéba annonce ses résultats pour le 1er semestre 2024 et son tournant stratégique vers une société commerciale. Amélioration du résultat opérationnel et visibilité financière jusqu'en 2025. Perspectives de développement biocontrôle et cosmétique

AMOEBA Développement Résultats Commercialisation Tournant Stratégique
PRESS RELEASE

published on 10/03/2024 at 17:45, 1 year 2 months ago

Amoéba: the first half of 2024 confirms the strategic pivot towards an industrial and commercial company from 2025 onwards
Amoéba reports strategic shift to commercial focus & positive operating income growth in H1 2024. Financial outlook secured until mid-2025. Development plans for biocontrol & cosmetics segments

AMOEBA Financial Results Biocontrol Cosmetics Strategic Shift
BRIEF

published on 10/02/2024 at 17:50, 1 year 2 months ago

AMOEBA : Nombre total de droits de vote et d'actions au 30 septembre 2024

AMOEBA Capital Droits De Vote Actions Marchés Financiers
BRIEF

published on 10/02/2024 at 17:50, 1 year 2 months ago

AMOEBA: Total number of voting rights and shares as of September 30, 2024

AMOEBA Voting Rights Capital Actions Financial Markets
PRESS RELEASE

published on 10/02/2024 at 17:45, 1 year 2 months ago

Déclaration du nombre total de droits de vote et du nombre d'actions composant le capital au 30 septembre 2024 conformément à l'article 223-16 du Règlement Général de l'Autorité des Marchés Financiers
Amoéba, greentech basée à Lyon, propose des solutions biologiques pour le traitement du risque microbiologique dans les secteurs des plantes et de la cosmétique

AMOEBA Cosmétique GreenTech Biologiques Microbiologique
BRIEF

published on 08/28/2024 at 17:50, 1 year 3 months ago

Amoéba Prepares for US Launch of AXPERA Product Line by 2025

Market Authorization 2025 Targets AXPERA Launch EPA Approval Biocontrol Products
BRIEF

published on 08/28/2024 at 17:50, 1 year 3 months ago

Amoéba se prépare au lancement de la gamme de produits AXPERA aux États-Unis d'ici 2025

Autorisation De Mise Sur Le Marché Objectifs 2025 Lancement D'AXPERA Approbation De L'EPA Produits De Lutte Biologique
PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 3 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA

Accesswire

Published on 12/05/2025 at 22:50, 30 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 1 hour 35 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 50 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 2 hours 20 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 4 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 8 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 22 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 53 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 4 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 20 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 20 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 20 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 20 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 2 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE